Gore Expands Line of GORE PROPATEN® Vascular Grafts
21 December 2009 - Integrated radial support offers all the benefits of a ringed graft while the GORE PROPATEN Bioactive Surface helps to improve thromboresistance and patency.
Vascular Surgeons Present Positive Study Results for the GORE PROPATEN® Vascular Graft and Updates to the GORE VIABAHN® Endoprosthesis
 21 September 2009 - Physicians report new information at the Society for Vascular Surgery's annual meeting
Vascular Surgeons Present Positive Study Results for the GORE PROPATEN® Vascular Graft and Updates to the GORE VIABAHN® Endoprosthesis
 17 September 2009 - Physicians report new information at the Society for Vascular Surgery's annual meeting
Vascular Surgeons Present Positive Study Results for the GORE PROPATEN® Vascular Graft and Updates to the GORE VIABAHN® Endoprosthesis
 18 March 2009 - Multi-center, multi-year, worldwide data presented adds to the growing body of evidence for ePTFE Heparin Vascular Graft
W. L. Gore & Associates Presents New Data and Clinical Updates at Transcatheter Cardiovascular Therapeutics (TCT) Conference 2008
 08 October 2008 - Gore continues commitment to clinical research with symposia, ongoing clinical studies and emerging technologies
W. L. Gore & Associates Announces Positive Interim Study Results for GORE PROPATEN Vascular Graft
 22 July 2008 - Interim and pivotal data presented at Society of Vascular Surgery's Annual Meeting
Gore Announces First Patient Enrolled in PRODIGY Study
 24 March 2008 - Post-market study to compare performance of GORE PROPATEN Vascular Graft todisadvantaged autologous vein graft in below-knee peripheral arterial disease bypasses.
W. L. Gore & Associates Announces Summary of GORE PROPATEN Vascular Graft Study Data Presented at 34th Annual VEITHsymposium®
 10 December 2007 - W. L. Gore & Associates (Gore) announced that interim results from multi-year, multi-center studies using the GORE PROPATEN Vascular Graft were presented recently at the 34th Annual VEITHsymposium® in New York.